214 related articles for article (PubMed ID: 34957101)
1. Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma.
Zhai W; Liang D; Duan F; Wong W; Yan Q; Gong L; Lai R; Dai S; Long H; Wang J
Front Cell Dev Biol; 2021; 9():769881. PubMed ID: 34957101
[TBL] [Abstract][Full Text] [Related]
2. Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB-IIA Lung Adenocarcinoma.
Zhai W; Gong L; Zheng Y; Yan Q; Lai R; Liang D; Wong W; Dai S; Wang J
Front Oncol; 2022; 12():851276. PubMed ID: 35402251
[TBL] [Abstract][Full Text] [Related]
3. Distinct Prognostic Factors of Ground Glass Opacity and Pure-Solid Lesion in Pathological Stage I Invasive Lung Adenocarcinoma.
Zhai WY; Wong WS; Duan FF; Liang DC; Gong L; Dai SQ; Wang JY
World J Oncol; 2022 Oct; 13(5):259-271. PubMed ID: 36406190
[TBL] [Abstract][Full Text] [Related]
4. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
[TBL] [Abstract][Full Text] [Related]
5. Differences in the prognostic implication of ground-glass opacity on CT according to pathological nodal status in lung cancers treated with lobectomy or pneumonectomy.
Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB
Eur Radiol; 2022 Jul; 32(7):4405-4413. PubMed ID: 35141781
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implication of consolidation-to-tumor ratio in early lung adenocarcinoma: a retrospective cross-sectional study.
Jing W; Liu M; Li W; Li D; Wu Y; Lv F
Quant Imaging Med Surg; 2024 May; 14(5):3366-3380. PubMed ID: 38720835
[TBL] [Abstract][Full Text] [Related]
7. Solid component ratio influences prognosis of GGO-featured IA stage invasive lung adenocarcinoma.
Sun F; Huang Y; Yang X; Zhan C; Xi J; Lin Z; Shi Y; Jiang W; Wang Q
Cancer Imaging; 2020 Dec; 20(1):87. PubMed ID: 33308323
[TBL] [Abstract][Full Text] [Related]
8. Effects of a ground-glass opacity component on the recurrence and survival of pathological stage IA3 lung adenocarcinoma: a multi-institutional retrospective study.
Xu SJ; Chen RQ; Tu JH; You CX; Chen C; Zhang ZF; Divisi D; Migliore M; Bongiolatti S; Durand M; Sato M; Kuroda H; Yang CF; Yu SB; Chen SC
Transl Lung Cancer Res; 2023 May; 12(5):1078-1092. PubMed ID: 37323166
[TBL] [Abstract][Full Text] [Related]
9. The presence of micropapillary and/or solid subtypes is an independent prognostic factor for patients undergoing curative resection for stage I lung adenocarcinoma with ground-glass opacity.
Li R; Li Z; Yang Z; Qiu B; Tan F; Xue Q; Gao S; He J
Transl Lung Cancer Res; 2024 Feb; 13(2):256-268. PubMed ID: 38496684
[TBL] [Abstract][Full Text] [Related]
10. A Nomogram Based on Consolidation Tumor Ratio Combined with Solid or Micropapillary Patterns for Postoperative Recurrence in Pathological Stage IA Lung Adenocarcinoma.
Zhang L; Liu J; Yang D; Ni Z; Lu X; Liu Y; Liu Z; Wang H; Feng M; Zhang Y
Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510119
[TBL] [Abstract][Full Text] [Related]
11. Distinct clinicopathologic factors and prognosis based on the presence of ground-glass opacity components in patients with resected stage I non-small cell lung cancer.
Wang C; Wu Y; Li J; Ren P; Gou Y; Shao J; Zhou Y; Xiao X; Tuersun P; Liu D; Zhang L; Li W
Ann Transl Med; 2020 Sep; 8(18):1133. PubMed ID: 33240982
[TBL] [Abstract][Full Text] [Related]
12. Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.
Miyoshi T; Aokage K; Katsumata S; Tane K; Ishii G; Tsuboi M
Ann Thorac Surg; 2019 Jul; 108(1):249-255. PubMed ID: 30876742
[TBL] [Abstract][Full Text] [Related]
13. Distinct Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer with Radiologic Part-Solid or Solid Lesions.
Fu F; Zhang Y; Wen Z; Zheng D; Gao Z; Han H; Deng L; Wang S; Liu Q; Li Y; Shen L; Shen X; Zhao Y; Zhao Z; Ye T; Xiang J; Zhang Y; Sun Y; Hu H; Chen H
J Thorac Oncol; 2019 Dec; 14(12):2133-2142. PubMed ID: 31437531
[TBL] [Abstract][Full Text] [Related]
14. A prognostic nomogram based on a new classification of combined micropapillary and solid components for stage IA invasive lung adenocarcinoma.
Huang W; Zhang H; Zhang Z; Zhang B; Sun X; Huo Y; Feng Y; Tian P; Mo H; Wang C
J Surg Oncol; 2022 Mar; 125(4):796-808. PubMed ID: 34862621
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of ground glass opacity on computed tomography in pathological stage I pulmonary adenocarcinoma: A meta-analysis.
Pan XL; Liao ZL; Yao H; Yan WJ; Wen DY; Wang Y; Li ZL
World J Clin Cases; 2021 Nov; 9(33):10222-10232. PubMed ID: 34904092
[TBL] [Abstract][Full Text] [Related]
16. Prognostic effect of ground-glass opacity in subcentimeter invasive lung adenocarcinoma.
Bai J; Fu F; Sun W; Deng C; Ma Z; Wang S; Deng L; Zhang Y; Chen H
J Thorac Dis; 2023 Apr; 15(4):1559-1571. PubMed ID: 37197537
[TBL] [Abstract][Full Text] [Related]
17. Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressiveness.
Mimae T; Miyata Y; Tsutani Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
JTCVS Open; 2022 Sep; 11():300-316. PubMed ID: 36172403
[TBL] [Abstract][Full Text] [Related]
18. Significance of histologic subtype size as a prognostic indicator in stage IA lung adenocarcinoma.
Jeon HW; Kim YD; Sim SB
J Thorac Dis; 2023 Oct; 15(10):5405-5413. PubMed ID: 37969277
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of tumour spread through air space in radiological subsolid and pure solid lung adenocarcinoma.
Zhong Y; Xu Y; Deng J; Wang T; Sun X; Chen D; Wu C; Hou L; Xie H; She Y; Xie D; Chen C
Eur J Cardiothorac Surg; 2021 Apr; 59(3):624-632. PubMed ID: 33188689
[TBL] [Abstract][Full Text] [Related]
20. Pan-Driver-Negatives versus Epidermal Growth Factor Receptor Mutants for C-Stage IA Lung Adenocarcinoma with Ground-Glass Opacity.
Li M; Xi J; Zhang H; Jin X; Zhang J; Feng M; Zhan C; Wang Q
Ann Thorac Cardiovasc Surg; 2022 Oct; 28(5):320-328. PubMed ID: 35644565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
